AI English summary of an SEC filing — figures as filed
Zoetis ZTSZoetis said total revenue for the 3 months ended September 30, 2024 increased $237 million (11%), or $297 million (14%) on an operational basis. Total revenue for the 9 months was $608 million (10%), with operational growth of $779 million (12%).
Key points
AI summaryZoetis said total revenue for the 3 months ended September 30, 2024 increased $237 million (11%), or $297 million (14%) on an operational basis. Total revenue for the 9 months was $608 million (10%), with operational growth of $779 million (12%).
Zoetis said its cost of sales as a percentage of revenue fell to 29.4% in Q3 from 29.7% a year earlier, and was unchanged at 29.0% for the 9 months. The company said SG&A expenses rose $40 million (8%) in Q3 and $107 million (7%) over the 9 months.
The company said its effective tax rate was 20.8% in Q3, compared with 16.9% a year earlier, and cited the tax loss benefit from the divestiture of Performance Livestock Analytics recorded in Q3 2023 among the factors. Restructuring charges and certain acquisition and divestiture-related costs were $5 million in Q3, and $51 million over the 9 months.
Zoetis said net cash used in financing activities was $1,915 million for the 9 months ended September 2024, compared with $2,712 million for the same period in 2023. In the 9 months of 2024, it repurchased 7.3 million shares for $1,295 million. As of 2021, $200 million remained of the $3.5 billion authorization, and in August 2024 the board approved a new program of up to $6 billion.
Key figures
Quarter ended September 30, 2024
- Revenue
- $2.4B
- Net income
- $682M
- EPS
- $1.50
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Quarterly revenue growth of Q3 2024 and 9-month revenue growth
Zoetis said total revenue for the 3 months ended September 30, 2024 increased $237 million (11%), or $297 million (14%) on an operational basis. Total revenue for the 9 months was $608 million (10%), with operational growth of $779 million (12%).
Source · Based on the MD&A text of the filing
Cost of sales and SG&A trends
Zoetis said its cost of sales as a percentage of revenue fell to 29.4% in Q3 from 29.7% a year earlier, and was unchanged at 29.0% for the 9 months. The company said SG&A expenses rose $40 million (8%) in Q3 and $107 million (7%) over the 9 months.
Source · Based on the MD&A text of the filing
Effective tax rate and restructuring costs in Q3
The company said its effective tax rate was 20.8% in Q3, compared with 16.9% a year earlier, and cited the tax loss benefit from the divestiture of Performance Livestock Analytics recorded in Q3 2023 among the factors. Restructuring charges and certain acquisition and divestiture-related costs were $5 million in Q3, and $51 million over the 9 months.
Source · Based on the MD&A text of the filing
Financing cash flow and share repurchases
Zoetis said net cash used in financing activities was $1,915 million for the 9 months ended September 2024, compared with $2,712 million for the same period in 2023. In the 9 months of 2024, it repurchased 7.3 million shares for $1,295 million. As of 2021, $200 million remained of the $3.5 billion authorization, and in August 2024 the board approved a new program of up to $6 billion.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…